Matrix Metalloproteinase Inhibition Improves Survival in an Orthotopic Model of Human Pancreatic Cancer

Journal of Gastrointestinal Surgery

Volumn 4, Issue 6, 2000, Pages 614-619

  Zervos, Emmanuel E ^a   Franz, Michael G ^b   Salhab, Khaled F ^b   Shafii, Alexis E ^b   Menendez, Julian ^b   Gower, William R ^c   Rosemurgy, Alexander S ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

BB 94; Gel zymography; Matrix metalloproteinase; Nude mouse; Pancreatic cancer

Indexed keywords

BATIMASTAT; DRUG DERIVATIVE; METALLOPROTEINASE; PHENYLALANINE; THIOPHENE DERIVATIVE;

ADENOCARCINOMA; ANIMAL; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DISEASE MODEL; DRUG ANTAGONISM; EXPERIMENTAL NEOPLASM; HUMAN; IMMUNOHISTOCHEMISTRY; MORTALITY; MOUSE; NEEDLE BIOPSY; NONPARAMETRIC TEST; NUDE MOUSE; PANCREAS TUMOR; PATHOLOGY; REFERENCE VALUE; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA; ANIMALS; BIOPSY, NEEDLE; CONFIDENCE INTERVALS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOHISTOCHEMISTRY; METALLOENDOPEPTIDASES; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; PANCREATIC NEOPLASMS; PHENYLALANINE; REFERENCE VALUES; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; THIOPHENES; TREATMENT OUTCOME;

EID: 0034331982     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(00)80111-0     Document Type: Article

References (27)

1. Murr MM, Sarr MG, Oshi A, vanHeerden JA. Pancreatic cancer. CA Cancer J Clin 1994;44:304-318.
2. Lillemoe KD. Current management of pancreatic carcinoma. Ann Surg 1995;221:133-148.
3. Mauch C, Krieg T, Bauer EA. Role of the extracellular matrix in the degradation of connective tissue. Arch Dermatol Res 1994;287:107-114.
4. DeClerck YA, Imren S. Protease inhibitors: Role and potential therapeutic use in human cancers. Eur J Cancer 1994;30:2170-2180.
5. Ray JM, Stetler-Stevenson WG. The role of matrix metalloproteinases and their inhibitors in tumour invasion, metastasis, and angiogenesis. Eur Res J 1994;7:2062-2072.
6. Brown PD. Matrix metalloproteinase inhibitors: A novel class of anticancer agents. Adv Enzyme Regul 1995;35:293-301.
7. Liabakk NB, Talbot I, Smith RA, Wilkinson K, Balkwill F. Matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9) type IV collagenase in colorectal cancer. Cancer Res 1996;56:190-196.
8. Levy JT, Cioce V, Sobel M, Garbisa S, Grigioni WF, Liotta LA, Stetler-Stevenson WG. Increased expression to the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res 1991;51:439-444.
9. Hoyhtya M, Fridman R, Komarek D, Porter-Jordan K, Stetler-Stevenson WG. Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies. Int J Cancer 1994;56:500-505.
10. Chenard MP, Rio MC, Chambon P, Bellocq J, Bassett P. Stromelysin-3 gene expression in human cancer: An overview. Invasion Metastasis 1994-95;14:269-275.
11. Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, Gokaslan Z, Liotta L, Nicolson G, Rao J. Differential expression of membrane type matrix metalloproteinases and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res 1996;56:384-392.
12. Eccles SA, Box GM, Court WJ, Bone EA, Thomas W, Brown PD. Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor Batimastat BB-94. Cancer Res 1996;56:2815-2822.
13. Wang X, Brown PD, Crimmin MJ, Hoffman RM. Matrix metalloproteinase inhibitor BB-94 (Batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res 1994;54:4726-4728.
14. Davies B, Brown PD, East N, Crimmin MJ, Balkwill FR. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian cancer xenografts. Cancer Res 1993;53:2087-2091.
15. Marincola FM, Drucker BJ, Siao DY, Hough KL, Holder WG. The nude mouse as a model for the study of human pancreatic cancer. J Surg Res 1989;47:520-529.
16. Furukawa T, Kubota T, Watanabe M, Kitajima M, Hoffman RM. A novel "patient-like" treatment model of human pancreatic cancer constructed using orthotopic transplantation of histologically intact human tumor tissue in nude mice. Cancer Res 1993;53:3070-3072.
17. Liu CD, Slice LW, Balasubramaniam A, Walsh JH, Newton TR, Saxton PE, McFadden DW. Y2 receptors decrease human pancreatic cancer growth and intracellular cyclic adenosine monophosphate levels. Surgery 1995;118:229-236.
18. Mong H, Chu TM. Characterization of the tumorigenic and metastatic properties of a human pancreatic tumor cell line (ASPC-1) implanted orthotopically into nude mice. Tumor Biol 1985;6:89-98.
19. Vezeridis MP, Doremus CM, Tibbetts LM, Tzanakakis G, Jackson BT. Invasion and metastasis following orthotopic transplantation of human pancreatic cancer in the nude mouse. J Surg Oncol 1989;40:261-265.
20. Zervos EE, Norman JG, Gower WR, Franz M, Rosemurgy AS. Matrix metalloproteinase inhibition attenuates human pancreatic cancer growth in vitro and decreases mortality and tumorigenesis in vivo. J Surg Res 1997;69:601-605.
21. Gower WR, Risch R, Godellas C, Fabri PJ. HPAC, a new human glucocorticoid-sensitive pancreatic ductal adenocarcinoma cell line. In Vitro Cell Dev Biol 1994;30A:151-161.
22. Brown PD, Bloxidge RE, Stuart NS, Gatter KC, Carmichael J. Association between expression of activated 72kD gelatinase and tumor spread in non-small cell lung cancer. J Natl Cancer Inst 1993;85:574-579.
23. Zervos EE, Shafii AE, Rosemurgy AS. Matrix metalloproteinase inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer. J Surg Res 1999;81: 65-68.
24. Zervos EE, Shafii AE, Haq M, Rosemurgy AS. Matrix metalloproteinase inhibition suppresses MMP-2 activity and activation of PANC-I cells in vitro. J Surg Res 1999;84:162-167.
25. Matrisian L. Matrix metalloproteinase gene expression. Ann N Y Acad Sci 1994;732:42-50.
26. Saarialho-Kere UK, Chang ES, Welgus HG, Parks WC. Distinct localization of collagenase and tissue inhibitor of metalloproteinase expression in wound healing associated with ulcerative pyogenic granuloma. J Clin Invest 1992;90:1952-1957.
27. Tryggvason K, Hoyhtya M, Pyke C. Type IV collagenases in invasive tumors. Breast Cancer Res Treatm 1993;24:209-218.